Literature DB >> 16643846

Effects of bone marrow stromal cell injection in an experimental glaucoma model.

Saiyuu Yu1, Teruyo Tanabe, Mari Dezawa, Hiroto Ishikawa, Nagahisa Yoshimura.   

Abstract

We investigated if bone marrow stromal cells (BMSCs) transplanted into the vitreous body of a glaucoma model eye could be integrated in the host retina and also whether they could rescue the retinal ganglion cells (RGCs) from death induced by the elevated intraocular pressure. Glaucoma was induced in the right eye of adult Wistar rats by ligating the episcleral veins. The GFP-expressing BMSCs (GFP-BMSCs) were injected into the vitreous body of both the control and the glaucomatous eyes. After transplantation, GFP-BMSCs were mostly present along with the inner limiting membrane and only a few cells were integrated into the ganglion cell layer. At 2 or 4 weeks after transplantation, GFP-BMSCs were observed to express various trophic factors. The BMSCs injected glaucoma model eyes showed less reduction in the number of RGCs compared to the glaucomatous eyes with PBS injection. This study suggests that BMSC transplantation may be worthy as a neuroprotective tool to treat glaucoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643846     DOI: 10.1016/j.bbrc.2006.03.231

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  50 in total

Review 1.  Using Electrical Stimulation to Enhance the Efficacy of Cell Transplantation Therapies for Neurodegenerative Retinal Diseases: Concepts, Challenges, and Future Perspectives.

Authors:  Abby Leigh Manthey; Wei Liu; Zhi Xin Jiang; Marcus Hiu Kong Lee; Jian Ji; Kwok-Fai So; Jimmy Shiu Ming Lai; Vincent Wing Hong Lee; Kin Chiu
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

2.  Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome.

Authors:  Thomas V Johnson; Nicholas W DeKorver; Victoria A Levasseur; Andrew Osborne; Alessia Tassoni; Barbara Lorber; Janosch P Heller; Rafael Villasmil; Natalie D Bull; Keith R Martin; Stanislav I Tomarev
Journal:  Brain       Date:  2013-10-30       Impact factor: 13.501

Review 3.  Protecting retinal ganglion cells.

Authors:  T Z Khatib; K R Martin
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

4.  Neuroprotective effects of BDNF and GDNF in intravitreally transplanted mesenchymal stem cells after optic nerve crush in mice.

Authors:  Zong-Li Hu; Ni Li; Xin Wei; Li Tang; Ting-Hua Wang; Xiao-Ming Chen
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

Review 5.  The emerging role of stem cells in ocular neurodegeneration: hype or hope?

Authors:  Neeru Jindal; Asok Mukhopadhyay; Akshay Anand
Journal:  Mol Cell Biochem       Date:  2012-06       Impact factor: 3.396

6.  Stem cell therapy for glaucoma: possibilities and practicalities.

Authors:  Thomas V Johnson; Natalie D Bull; Keith R Martin
Journal:  Expert Rev Ophthalmol       Date:  2011-04-01

Review 7.  Progress of mesenchymal stem cell therapy for neural and retinal diseases.

Authors:  Tsz Kin Ng; Veronica R Fortino; Daniel Pelaez; Herman S Cheung
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

8.  Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma.

Authors:  Thomas V Johnson; Natalie D Bull; David P Hunt; Nephtali Marina; Stanislav I Tomarev; Keith R Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

9.  Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion.

Authors:  Na Li; Xiao-rong Li; Jia-qin Yuan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-16       Impact factor: 3.117

10.  Embryonic retinal cells and support to mature retinal neurons.

Authors:  Jennifer J Stanke; Andy J Fischer
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.